Cited by 248Nicotinic Acetylcholine Receptors StudyNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Nicotinic Receptor Activation in Human Cerebral Cortical Interneurons: a Mechanism for Inhibition and Disinhibition of Neuronal Networks

Open access

Abstract

Cholinergic control of the activity of human cerebral cortical circuits has long been thought to be accounted for by the interaction of acetylcholine (ACh) with muscarinic receptors. Here we report the discovery of functional nicotinic receptors (nAChRs) in interneurons of the human cerebral cortex and discuss the physiological and clinical implications of these findings. The whole-cell mode of the patch-clamp technique was used to record responses triggered by U-tube application of the nonselective agonist ACh and of the α7-nAChR-selective agonist choline to interneurons visualized by means of infrared-assisted videomicroscopy in slices of the human cerebral cortex. Choline induced rapidly desensitizing whole-cell currents that, being sensitive to blockade by methyllycaconitine (MLA; 50 n m), were most likely subserved by an α7-like nAChR. In contrast, ACh evoked slowly decaying whole-cell currents that, being sensitive to blockade by dihydro-β-erythroidine (DHβE; 10 μ m), were most likely subserved by an α4β2-like nAChR. Application of ACh (but not choline) to the slices also triggered GABAergic postsynaptic currents (PSCs). Evidence is provided that ACh-evoked PSCs are the result of activation of α4β2-like nAChRs present in preterminal axon segments and/or in presynaptic terminals of interneurons. Thus, nAChRs can relay inhibitory and/or disinhibitory signals to pyramidal neurons and thereby modulate the activity of neuronal circuits in the human cerebral cortex. These mechanisms, which appear to be retained across species, can account for the involvement of nAChRs in cognitive functions and in certain neuropathological conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.20-01-00066.2000

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 61

  1. Albuquerque, 1996, Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function., J Pharmacol Exp Ther, 280, 1117, 10.1016/S0022-3565(24)36503-6 · DOI
  2. Alkondon, 1997, Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons of rat hippocampal slices., J Pharmacol Exp Ther, 283, 1396, 10.1016/S0022-3565(24)37139-3 · DOI · Paper page
  3. 10.1016/S0006-8993(98)00880-4 · DOI
  4. 10.1523/JNEUROSCI.19-07-02693.1999 · DOI
  5. 10.1523/JNEUROSCI.19-15-06475.1999 · DOI · Paper page
  6. 10.1016/0304-3940(96)12679-3 · DOI
  7. Ben-Shlomo, 1997, The epidemiology of Parkinson's disease., Ballieres Clin Neurol, 6, 55
  8. 10.1016/S0306-4522(97)00026-2 · DOI
  9. 10.1016/S0165-0173(97)00040-4 · DOI · Paper page
  10. Cummins, 1993, Human neocortical excitability is decreased during anoxia via sodium channel modulation., J Clin Invest, 91, 608, 10.1172/JCI116241 · DOI
  11. 10.1176/ajp.155.11.1490 · DOI
  12. 10.1016/S0896-6273(00)80112-9 · DOI · Paper page
  13. Dempster J (1989) Computer analysis of electrophysiological signals. in Microcomputers in physiology: a practical approach, ed Frazer PJ (IRI, Oxford), pp 51–93.
  14. 10.1093/hmg/6.8.1329 · DOI
  15. 10.1016/0006-8993(93)90487-8 · DOI
  16. 10.1523/JNEUROSCI.18-20-08228.1998 · DOI
  17. 10.1111/j.1471-4159.1992.tb08440.x · DOI
  18. 10.1016/S0006-8993(96)00915-8 · DOI
  19. 10.1016/S0301-0082(97)00034-8 · DOI
  20. Gray, 1996, Hippocampal synaptic transmission enhanced by low concentrations of nicotine., Nature, 389, 713, 10.1038/383713a0 · DOI
  21. Hagan, 1997, Parkinson's disease: prospects for improved drug therapy., Trends Pharmacol Sci, 18, 156, 10.1016/S0165-6147(97)90612-X · DOI
  22. Halliwell, 1989, Cholinergic responses in human neocortical neurones., EXS, 57, 138
  23. Hietala, 1996, Dopamine in schizophrenia., Ann Med, 28, 557, 10.3109/07853899608999120 · DOI
  24. Hilmas, 1998, Nicotinic receptor activation modulates GABA release from neurons in human cortical slices., Soc Neurosci Abstr, 24, 1581
  25. Isokawa, 1996, Decrement of GABAA receptor-mediated inhibitory postsynaptic currents in dentate granule cells in epileptic hippocampus., J Neurophysiol, 75, 1901, 10.1152/jn.1996.75.5.1901 · DOI
  26. Isokawa, 1997, Glutamate currents in morphologically identified human dentate granule cells in temporal lobe epilepsy., J Neurophysiol, 77, 3355, 10.1152/jn.1997.77.6.3355 · DOI
  27. Kawaguchi, 1993, Groupings of nonpyramidal and pyramidal cells with specific physiological and morphological characteristics in rat frontal cortex., J Neurophysiol, 69, 416, 10.1152/jn.1993.69.2.416 · DOI
  28. 10.1523/JNEUROSCI.17-23-09035.1997 · DOI
  29. 10.1523/JNEUROSCI.17-02-00576.1997 · DOI
  30. 10.1523/JNEUROSCI.13-06-02680.1993 · DOI
  31. 10.1093/schbul/22.3.431 · DOI
  32. 10.1073/pnas.93.24.13541 · DOI
  33. 10.1007/s002130050667 · DOI
  34. 10.1016/S0079-6123(08)62094-4 · DOI
  35. Lu, 1998, Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes., J Pharmacol Exp Ther, 287, 648, 10.1016/S0022-3565(24)37839-5 · DOI
  36. 10.1080/00223980.1983.9923599 · DOI
  37. 10.1016/0306-4522(94)90187-2 · DOI
  38. Miyake, 1995, Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species., Mol Pharmacol, 48, 407, 10.1016/S0026-895X(25)10488-4 · DOI
  39. Morens, 1996, Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease., Am J Epidemiol, 144, 400, 10.1093/oxfordjournals.aje.a008941 · DOI
  40. Newhouse, 1996, Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics., Drugs Aging, 11, 206, 10.2165/00002512-199711030-00005 · DOI
  41. 10.1002/syn.890190203 · DOI
  42. 10.1016/S0042-6989(97)00076-X · DOI
  43. 10.1007/s002130050553 · DOI
  44. 10.1007/BF00427447 · DOI
  45. Peng, 1994, Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes., Mol Pharmacol, 45, 546, 10.1016/S0026-895X(25)10029-1 · DOI
  46. Pereira, 1997, Ligand-gated ion channels on human neurons., Soc Neurosci Abstr, 23, 374
  47. 10.1038/37120 · DOI · Paper page
  48. 10.1523/JNEUROSCI.18-18-07075.1998 · DOI · Paper page
  49. Raiteri, 1990, Presynaptic muscarinic receptors in the central nervous system., Ann NY Acad Sci, 604, 113, 10.1111/j.1749-6632.1990.tb31987.x · DOI
  50. 10.1523/JNEUROSCI.17-21-08353.1997 · DOI
  51. Russo, 1993, Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors., J Pharmacol Exp Ther, 266, 142, 10.1016/S0022-3565(25)38334-5 · DOI
  52. Rye, 1997, Contributions of the pedunculopontine region to normal and altered REM sleep., Sleep, 20, 757, 10.1093/sleep/20.9.757 · DOI
  53. 10.1176/ajp.155.8.1009 · DOI
  54. 10.1523/JNEUROSCI.19-01-00085.1999 · DOI
  55. 10.1016/S0925-4927(98)00006-7 · DOI
  56. 10.4088/JCP.v58n0104 · DOI
  57. 10.1046/j.1460-9568.1999.00676.x · DOI
  58. Whitehouse, 1995, Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications., Alzheimer Dis Assoc Disord, 9, 3, 10.1097/00002093-199501002-00002 · DOI · Paper page
  59. Whitehouse, 1988, Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study., Neurology, 38, 720, 10.1212/WNL.38.5.720 · DOI
  60. Zhang, 1993, Nicotinic cholinoceptor-mediated excitatory postsynaptic potentials in rat nucleus ambiguus., Exp Brain Res, 96, 83, 10.1007/BF00230441 · DOI
  61. Zilles, 1989, Distribution of cholinergic receptors in the rat and human neocortex., EXS, 57, 212

Cited by

Sorted by citations

Metadata

Authors
Alkondon, M., Pereira, E. F. R., Eisenberg, H. M., & Albuquerque, E. X.
Affiliations
  • University of Maryland, Baltimore (US)
  • Universidade Federal do Rio de Janeiro (BR)
Venue
The Journal of Neuroscience
Published
2000-01-01
Volume
20
Issue
1
Pages
66-75
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W1939947624
Cited by
248
References
6
Citations by year
2025: 1 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 10 · 2017: 5 · 2016: 4 · 2015: 8 · 2014: 6 · 2013: 12 · 2012: 10
FWCI
9.05
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01es005730-07)
  • U.S. Public Health Service
  • National Institute of Neurological Disorders and Stroke (R01NS025296, NS 25296)
  • National Institute of Environmental Health Sciences (ES 05730)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords
nicotinic acetylcholine receptors, alpha7 nicotinic acetylcholine receptor, alpha4beta2 nicotinic receptor, cholinergic modulation, acetylcholine, choline, presynaptic nicotinic receptors, neuronal inhibition, disinhibition, human cerebral cortex, methyllycaconitine, dihydro-beta-erythroidine, cognitive function, neuropathology
MeSH terms
Acetylcholine, Aconitine, Adolescent, Adult, Bicuculline, Cerebral Cortex, Child, Choline, Dihydro-beta-Erythroidine, Female, gamma-Aminobutyric Acid, Humans, Insecticides, Interneurons, Male, Middle Aged, Nerve Net, Neural Inhibition, Organ Culture Techniques, Receptors, Nicotinic, Stimulation, Chemical, Tetrodotoxin, Quisqualic Acid, Patch-Clamp Techniques, Excitatory Amino Acid Agonists, GABA Antagonists, Excitatory Postsynaptic Potentials, alpha7 Nicotinic Acetylcholine Receptor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review